Request for Covid-19 Impact Assessment of this Report
The United States Sumatriptan Succinate market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sumatriptan Succinate market, reaching US$ million by the year 2028. As for the Europe Sumatriptan Succinate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sumatriptan Succinate players cover GlaxoSmithKline, Pfizer, Teva, and Endo Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sumatriptan Succinate market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablet
Subcutaneous Injection
Nasal Spray
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Drug Stores
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GlaxoSmithKline
Pfizer
Teva
Endo Pharmaceuticals
Mylan
Merck
Sun Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sumatriptan Succinate Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sumatriptan Succinate by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sumatriptan Succinate by Country/Region, 2017, 2022 & 2028
2.2 Sumatriptan Succinate Segment by Type
2.2.1 Tablet
2.2.2 Subcutaneous Injection
2.2.3 Nasal Spray
2.3 Sumatriptan Succinate Sales by Type
2.3.1 Global Sumatriptan Succinate Sales Market Share by Type (2017-2022)
2.3.2 Global Sumatriptan Succinate Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sumatriptan Succinate Sale Price by Type (2017-2022)
2.4 Sumatriptan Succinate Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Drug Stores
2.5 Sumatriptan Succinate Sales by Application
2.5.1 Global Sumatriptan Succinate Sale Market Share by Application (2017-2022)
2.5.2 Global Sumatriptan Succinate Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sumatriptan Succinate Sale Price by Application (2017-2022)
3 Global Sumatriptan Succinate by Company
3.1 Global Sumatriptan Succinate Breakdown Data by Company
3.1.1 Global Sumatriptan Succinate Annual Sales by Company (2020-2022)
3.1.2 Global Sumatriptan Succinate Sales Market Share by Company (2020-2022)
3.2 Global Sumatriptan Succinate Annual Revenue by Company (2020-2022)
3.2.1 Global Sumatriptan Succinate Revenue by Company (2020-2022)
3.2.2 Global Sumatriptan Succinate Revenue Market Share by Company (2020-2022)
3.3 Global Sumatriptan Succinate Sale Price by Company
3.4 Key Manufacturers Sumatriptan Succinate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sumatriptan Succinate Product Location Distribution
3.4.2 Players Sumatriptan Succinate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sumatriptan Succinate by Geographic Region
4.1 World Historic Sumatriptan Succinate Market Size by Geographic Region (2017-2022)
4.1.1 Global Sumatriptan Succinate Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sumatriptan Succinate Annual Revenue by Geographic Region
4.2 World Historic Sumatriptan Succinate Market Size by Country/Region (2017-2022)
4.2.1 Global Sumatriptan Succinate Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sumatriptan Succinate Annual Revenue by Country/Region
4.3 Americas Sumatriptan Succinate Sales Growth
4.4 APAC Sumatriptan Succinate Sales Growth
4.5 Europe Sumatriptan Succinate Sales Growth
4.6 Middle East & Africa Sumatriptan Succinate Sales Growth
5 Americas
5.1 Americas Sumatriptan Succinate Sales by Country
5.1.1 Americas Sumatriptan Succinate Sales by Country (2017-2022)
5.1.2 Americas Sumatriptan Succinate Revenue by Country (2017-2022)
5.2 Americas Sumatriptan Succinate Sales by Type
5.3 Americas Sumatriptan Succinate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sumatriptan Succinate Sales by Region
6.1.1 APAC Sumatriptan Succinate Sales by Region (2017-2022)
6.1.2 APAC Sumatriptan Succinate Revenue by Region (2017-2022)
6.2 APAC Sumatriptan Succinate Sales by Type
6.3 APAC Sumatriptan Succinate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sumatriptan Succinate by Country
7.1.1 Europe Sumatriptan Succinate Sales by Country (2017-2022)
7.1.2 Europe Sumatriptan Succinate Revenue by Country (2017-2022)
7.2 Europe Sumatriptan Succinate Sales by Type
7.3 Europe Sumatriptan Succinate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sumatriptan Succinate by Country
8.1.1 Middle East & Africa Sumatriptan Succinate Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sumatriptan Succinate Revenue by Country (2017-2022)
8.2 Middle East & Africa Sumatriptan Succinate Sales by Type
8.3 Middle East & Africa Sumatriptan Succinate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sumatriptan Succinate
10.3 Manufacturing Process Analysis of Sumatriptan Succinate
10.4 Industry Chain Structure of Sumatriptan Succinate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sumatriptan Succinate Distributors
11.3 Sumatriptan Succinate Customer
12 World Forecast Review for Sumatriptan Succinate by Geographic Region
12.1 Global Sumatriptan Succinate Market Size Forecast by Region
12.1.1 Global Sumatriptan Succinate Forecast by Region (2023-2028)
12.1.2 Global Sumatriptan Succinate Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sumatriptan Succinate Forecast by Type
12.7 Global Sumatriptan Succinate Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Sumatriptan Succinate Product Offered
13.1.3 GlaxoSmithKline Sumatriptan Succinate Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Sumatriptan Succinate Product Offered
13.2.3 Pfizer Sumatriptan Succinate Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Sumatriptan Succinate Product Offered
13.3.3 Teva Sumatriptan Succinate Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Endo Pharmaceuticals
13.4.1 Endo Pharmaceuticals Company Information
13.4.2 Endo Pharmaceuticals Sumatriptan Succinate Product Offered
13.4.3 Endo Pharmaceuticals Sumatriptan Succinate Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Endo Pharmaceuticals Main Business Overview
13.4.5 Endo Pharmaceuticals Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Sumatriptan Succinate Product Offered
13.5.3 Mylan Sumatriptan Succinate Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Sumatriptan Succinate Product Offered
13.6.3 Merck Sumatriptan Succinate Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Sun Pharmaceutical
13.7.1 Sun Pharmaceutical Company Information
13.7.2 Sun Pharmaceutical Sumatriptan Succinate Product Offered
13.7.3 Sun Pharmaceutical Sumatriptan Succinate Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sun Pharmaceutical Main Business Overview
13.7.5 Sun Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Sumatriptan Succinate Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sumatriptan Succinate Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Subcutaneous Injection
Table 5. Major Players of Nasal Spray
Table 6. Global Sumatriptan Succinate Sales by Type (2017-2022) & (K Doses)
Table 7. Global Sumatriptan Succinate Sales Market Share by Type (2017-2022)
Table 8. Global Sumatriptan Succinate Revenue by Type (2017-2022) & ($ million)
Table 9. Global Sumatriptan Succinate Revenue Market Share by Type (2017-2022)
Table 10. Global Sumatriptan Succinate Sale Price by Type (2017-2022) & (US$/Dose)
Table 11. Global Sumatriptan Succinate Sales by Application (2017-2022) & (K Doses)
Table 12. Global Sumatriptan Succinate Sales Market Share by Application (2017-2022)
Table 13. Global Sumatriptan Succinate Revenue by Application (2017-2022)
Table 14. Global Sumatriptan Succinate Revenue Market Share by Application (2017-2022)
Table 15. Global Sumatriptan Succinate Sale Price by Application (2017-2022) & (US$/Dose)
Table 16. Global Sumatriptan Succinate Sales by Company (2020-2022) & (K Doses)
Table 17. Global Sumatriptan Succinate Sales Market Share by Company (2020-2022)
Table 18. Global Sumatriptan Succinate Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Sumatriptan Succinate Revenue Market Share by Company (2020-2022)
Table 20. Global Sumatriptan Succinate Sale Price by Company (2020-2022) & (US$/Dose)
Table 21. Key Manufacturers Sumatriptan Succinate Producing Area Distribution and Sales Area
Table 22. Players Sumatriptan Succinate Products Offered
Table 23. Sumatriptan Succinate Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Sumatriptan Succinate Sales by Geographic Region (2017-2022) & (K Doses)
Table 27. Global Sumatriptan Succinate Sales Market Share Geographic Region (2017-2022)
Table 28. Global Sumatriptan Succinate Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Sumatriptan Succinate Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Sumatriptan Succinate Sales by Country/Region (2017-2022) & (K Doses)
Table 31. Global Sumatriptan Succinate Sales Market Share by Country/Region (2017-2022)
Table 32. Global Sumatriptan Succinate Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Sumatriptan Succinate Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Sumatriptan Succinate Sales by Country (2017-2022) & (K Doses)
Table 35. Americas Sumatriptan Succinate Sales Market Share by Country (2017-2022)
Table 36. Americas Sumatriptan Succinate Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Sumatriptan Succinate Revenue Market Share by Country (2017-2022)
Table 38. Americas Sumatriptan Succinate Sales by Type (2017-2022) & (K Doses)
Table 39. Americas Sumatriptan Succinate Sales Market Share by Type (2017-2022)
Table 40. Americas Sumatriptan Succinate Sales by Application (2017-2022) & (K Doses)
Table 41. Americas Sumatriptan Succinate Sales Market Share by Application (2017-2022)
Table 42. APAC Sumatriptan Succinate Sales by Region (2017-2022) & (K Doses)
Table 43. APAC Sumatriptan Succinate Sales Market Share by Region (2017-2022)
Table 44. APAC Sumatriptan Succinate Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Sumatriptan Succinate Revenue Market Share by Region (2017-2022)
Table 46. APAC Sumatriptan Succinate Sales by Type (2017-2022) & (K Doses)
Table 47. APAC Sumatriptan Succinate Sales Market Share by Type (2017-2022)
Table 48. APAC Sumatriptan Succinate Sales by Application (2017-2022) & (K Doses)
Table 49. APAC Sumatriptan Succinate Sales Market Share by Application (2017-2022)
Table 50. Europe Sumatriptan Succinate Sales by Country (2017-2022) & (K Doses)
Table 51. Europe Sumatriptan Succinate Sales Market Share by Country (2017-2022)
Table 52. Europe Sumatriptan Succinate Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Sumatriptan Succinate Revenue Market Share by Country (2017-2022)
Table 54. Europe Sumatriptan Succinate Sales by Type (2017-2022) & (K Doses)
Table 55. Europe Sumatriptan Succinate Sales Market Share by Type (2017-2022)
Table 56. Europe Sumatriptan Succinate Sales by Application (2017-2022) & (K Doses)
Table 57. Europe Sumatriptan Succinate Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Sumatriptan Succinate Sales by Country (2017-2022) & (K Doses)
Table 59. Middle East & Africa Sumatriptan Succinate Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Sumatriptan Succinate Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Sumatriptan Succinate Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Sumatriptan Succinate Sales by Type (2017-2022) & (K Doses)
Table 63. Middle East & Africa Sumatriptan Succinate Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Sumatriptan Succinate Sales by Application (2017-2022) & (K Doses)
Table 65. Middle East & Africa Sumatriptan Succinate Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Sumatriptan Succinate
Table 67. Key Market Challenges & Risks of Sumatriptan Succinate
Table 68. Key Industry Trends of Sumatriptan Succinate
Table 69. Sumatriptan Succinate Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Sumatriptan Succinate Distributors List
Table 72. Sumatriptan Succinate Customer List
Table 73. Global Sumatriptan Succinate Sales Forecast by Region (2023-2028) & (K Doses)
Table 74. Global Sumatriptan Succinate Sales Market Forecast by Region
Table 75. Global Sumatriptan Succinate Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Sumatriptan Succinate Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Sumatriptan Succinate Sales Forecast by Country (2023-2028) & (K Doses)
Table 78. Americas Sumatriptan Succinate Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Sumatriptan Succinate Sales Forecast by Region (2023-2028) & (K Doses)
Table 80. APAC Sumatriptan Succinate Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Sumatriptan Succinate Sales Forecast by Country (2023-2028) & (K Doses)
Table 82. Europe Sumatriptan Succinate Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Sumatriptan Succinate Sales Forecast by Country (2023-2028) & (K Doses)
Table 84. Middle East & Africa Sumatriptan Succinate Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Sumatriptan Succinate Sales Forecast by Type (2023-2028) & (K Doses)
Table 86. Global Sumatriptan Succinate Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Sumatriptan Succinate Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Sumatriptan Succinate Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Sumatriptan Succinate Sales Forecast by Application (2023-2028) & (K Doses)
Table 90. Global Sumatriptan Succinate Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Sumatriptan Succinate Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Sumatriptan Succinate Revenue Market Share Forecast by Application (2023-2028)
Table 93. GlaxoSmithKline Basic Information, Sumatriptan Succinate Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Sumatriptan Succinate Product Offered
Table 95. GlaxoSmithKline Sumatriptan Succinate Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 96. GlaxoSmithKline Main Business
Table 97. GlaxoSmithKline Latest Developments
Table 98. Pfizer Basic Information, Sumatriptan Succinate Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Sumatriptan Succinate Product Offered
Table 100. Pfizer Sumatriptan Succinate Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Teva Basic Information, Sumatriptan Succinate Manufacturing Base, Sales Area and Its Competitors
Table 104. Teva Sumatriptan Succinate Product Offered
Table 105. Teva Sumatriptan Succinate Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 106. Teva Main Business
Table 107. Teva Latest Developments
Table 108. Endo Pharmaceuticals Basic Information, Sumatriptan Succinate Manufacturing Base, Sales Area and Its Competitors
Table 109. Endo Pharmaceuticals Sumatriptan Succinate Product Offered
Table 110. Endo Pharmaceuticals Sumatriptan Succinate Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 111. Endo Pharmaceuticals Main Business
Table 112. Endo Pharmaceuticals Latest Developments
Table 113. Mylan Basic Information, Sumatriptan Succinate Manufacturing Base, Sales Area and Its Competitors
Table 114. Mylan Sumatriptan Succinate Product Offered
Table 115. Mylan Sumatriptan Succinate Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 116. Mylan Main Business
Table 117. Mylan Latest Developments
Table 118. Merck Basic Information, Sumatriptan Succinate Manufacturing Base, Sales Area and Its Competitors
Table 119. Merck Sumatriptan Succinate Product Offered
Table 120. Merck Sumatriptan Succinate Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 121. Merck Main Business
Table 122. Merck Latest Developments
Table 123. Sun Pharmaceutical Basic Information, Sumatriptan Succinate Manufacturing Base, Sales Area and Its Competitors
Table 124. Sun Pharmaceutical Sumatriptan Succinate Product Offered
Table 125. Sun Pharmaceutical Sumatriptan Succinate Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 126. Sun Pharmaceutical Main Business
Table 127. Sun Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Sumatriptan Succinate
Figure 2. Sumatriptan Succinate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sumatriptan Succinate Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Sumatriptan Succinate Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sumatriptan Succinate Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Subcutaneous Injection
Figure 11. Product Picture of Nasal Spray
Figure 12. Global Sumatriptan Succinate Sales Market Share by Type in 2021
Figure 13. Global Sumatriptan Succinate Revenue Market Share by Type (2017-2022)
Figure 14. Sumatriptan Succinate Consumed in Hospital Pharmacies
Figure 15. Global Sumatriptan Succinate Market: Hospital Pharmacies (2017-2022) & (K Doses)
Figure 16. Sumatriptan Succinate Consumed in Drug Stores
Figure 17. Global Sumatriptan Succinate Market: Drug Stores (2017-2022) & (K Doses)
Figure 18. Global Sumatriptan Succinate Sales Market Share by Application (2017-2022)
Figure 19. Global Sumatriptan Succinate Revenue Market Share by Application in 2021
Figure 20. Sumatriptan Succinate Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Sumatriptan Succinate Revenue Market Share by Company in 2021
Figure 22. Global Sumatriptan Succinate Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Sumatriptan Succinate Revenue Market Share by Geographic Region in 2021
Figure 24. Global Sumatriptan Succinate Sales Market Share by Region (2017-2022)
Figure 25. Global Sumatriptan Succinate Revenue Market Share by Country/Region in 2021
Figure 26. Americas Sumatriptan Succinate Sales 2017-2022 (K Doses)
Figure 27. Americas Sumatriptan Succinate Revenue 2017-2022 ($ Millions)
Figure 28. APAC Sumatriptan Succinate Sales 2017-2022 (K Doses)
Figure 29. APAC Sumatriptan Succinate Revenue 2017-2022 ($ Millions)
Figure 30. Europe Sumatriptan Succinate Sales 2017-2022 (K Doses)
Figure 31. Europe Sumatriptan Succinate Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Sumatriptan Succinate Sales 2017-2022 (K Doses)
Figure 33. Middle East & Africa Sumatriptan Succinate Revenue 2017-2022 ($ Millions)
Figure 34. Americas Sumatriptan Succinate Sales Market Share by Country in 2021
Figure 35. Americas Sumatriptan Succinate Revenue Market Share by Country in 2021
Figure 36. United States Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Sumatriptan Succinate Sales Market Share by Region in 2021
Figure 41. APAC Sumatriptan Succinate Revenue Market Share by Regions in 2021
Figure 42. China Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Sumatriptan Succinate Sales Market Share by Country in 2021
Figure 49. Europe Sumatriptan Succinate Revenue Market Share by Country in 2021
Figure 50. Germany Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Sumatriptan Succinate Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Sumatriptan Succinate Revenue Market Share by Country in 2021
Figure 57. Egypt Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Sumatriptan Succinate Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Sumatriptan Succinate in 2021
Figure 63. Manufacturing Process Analysis of Sumatriptan Succinate
Figure 64. Industry Chain Structure of Sumatriptan Succinate
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...